Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data - PubMed (original) (raw)
. 2012 Jul;51(7):696-706.
doi: 10.1002/gcc.21956. Epub 2012 Mar 27.
Affiliations
- PMID: 22454324
- DOI: 10.1002/gcc.21956
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
Marieke L Kuijjer et al. Genes Chromosomes Cancer. 2012 Jul.
Abstract
High-grade osteosarcoma is a tumor with a complex genomic profile, occurring primarily in adolescents with a second peak at middle age. The extensive genomic alterations obscure the identification of genes driving tumorigenesis during osteosarcoma development. To identify such driver genes, we integrated DNA copy number profiles (Affymetrix SNP 6.0) of 32 diagnostic biopsies with 84 expression profiles (Illumina Human-6 v2.0) of high-grade osteosarcoma as compared with its putative progenitor cells, i.e., mesenchymal stem cells (n = 12) or osteoblasts (n = 3). In addition, we performed paired analyses between copy number and expression profiles of a subset of 29 patients for which both DNA and mRNA profiles were available. Integrative analyses were performed in Nexus Copy Number software and statistical language R. Paired analyses were performed on all probes detecting significantly differentially expressed genes in corresponding LIMMA analyses. For both nonpaired and paired analyses, copy number aberration frequency was set to >35%. Nonpaired and paired integrative analyses resulted in 45 and 101 genes, respectively, which were present in both analyses using different control sets. Paired analyses detected >90% of all genes found with the corresponding nonpaired analyses. Remarkably, approximately twice as many genes as found in the corresponding nonpaired analyses were detected. Affected genes were intersected with differentially expressed genes in osteosarcoma cell lines, resulting in 31 new osteosarcoma driver genes. Cell division related genes, such as MCM4 and LATS2, were overrepresented and genomic instability was predictive for metastasis-free survival, suggesting that deregulation of the cell cycle is a driver of osteosarcomagenesis.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
- Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA. Maire G, et al. Cancer Genet. 2011 Mar;204(3):138-46. doi: 10.1016/j.cancergen.2010.12.012. Cancer Genet. 2011. PMID: 21504713 - Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R, Fanale D, Drago-Ferrante R, Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan V, Tesoriere G, Vento R, Russo A. Di Fiore R, et al. J Cell Physiol. 2013 Jun;228(6):1189-201. doi: 10.1002/jcp.24272. J Cell Physiol. 2013. PMID: 23129384 - Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM. Buddingh EP, et al. Clin Cancer Res. 2011 Apr 15;17(8):2110-9. doi: 10.1158/1078-0432.CCR-10-2047. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372215 - Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
van Dartel M, Hulsebos TJ. van Dartel M, et al. Cancer Genet Cytogenet. 2004 Aug;153(1):77-80. doi: 10.1016/j.cancergencyto.2004.03.007. Cancer Genet Cytogenet. 2004. PMID: 15325100 Review. - Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.
Kuijjer ML, Hogendoorn PC, Cleton-Jansen AM. Kuijjer ML, et al. Int J Cancer. 2013 Dec 1;133(11):2512-21. doi: 10.1002/ijc.28124. Epub 2013 Mar 16. Int J Cancer. 2013. PMID: 23436697 Review.
Cited by
- Genome-Informed Targeted Therapy for Osteosarcoma.
Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, Hawkins DS, Sweet-Cordero EA. Sayles LC, et al. Cancer Discov. 2019 Jan;9(1):46-63. doi: 10.1158/2159-8290.CD-17-1152. Epub 2018 Sep 28. Cancer Discov. 2019. PMID: 30266815 Free PMC article. - Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.
Baranski Z, de Jong Y, Ilkova T, Peterse EF, Cleton-Jansen AM, van de Water B, Hogendoorn PC, Bovée JV, Danen EH. Baranski Z, et al. Oncotarget. 2015 Nov 3;6(34):36113-25. doi: 10.18632/oncotarget.5333. Oncotarget. 2015. PMID: 26416351 Free PMC article. - Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.
Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J, Rodriguez R. Abarrategi A, et al. Stem Cells Int. 2016;2016:3631764. doi: 10.1155/2016/3631764. Epub 2016 Jun 5. Stem Cells Int. 2016. PMID: 27366153 Free PMC article. Review. - Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma.
Pandya PH, Cheng L, Saadatzadeh MR, Bijangi-Vishehsaraei K, Tang S, Sinn AL, Trowbridge MA, Coy KL, Bailey BJ, Young CN, Ding J, Dobrota EA, Dyer S, Elmi A, Thompson Q, Barghi F, Shultz J, Albright EA, Shannon HE, Murray ME, Marshall MS, Ferguson MJ, Bertrand TE, Wurtz LD, Batra S, Li L, Renbarger JL, Pollok KE. Pandya PH, et al. Cancers (Basel). 2020 Aug 26;12(9):2426. doi: 10.3390/cancers12092426. Cancers (Basel). 2020. PMID: 32859084 Free PMC article. - Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis.
Das M, Prasad SB, Yadav SS, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G. Das M, et al. PLoS One. 2013 Jul 17;8(7):e69607. doi: 10.1371/journal.pone.0069607. Print 2013. PLoS One. 2013. PMID: 23874974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases